Inhibitory postsynaptic potential

pathway activity — cross-omics
GO:0060080Cross-omicsRNA → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Inhibitory postsynaptic potential pathway is significantly associated with the RNA expression of multiple genes, with the SCLC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CD48, EVI2A, and CCR5, each associated with the pathway in up to 26 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Inhibitory postsynaptic potential activity versus CD48 in SCLC (Pearson r = -0.24).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SCLCCD48 →-2.061-1.084<.001<.001326
SCLCEVI2A →-1.479-0.665<.001<.001326
SCLCCCR5 →-2.111-0.715.001<.001326
SCLCCCL4 →-1.541-0.659.001.003326
PCPGCD300A →-1.127-0.037<.001<.001325
SCLCCLEC4A →-1.686-0.764<.001<.001325
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060080 vs CD48 — SCLC

Per-sample scatter of Inhibitory postsynaptic potential activity vs CD48 in SCLC.

Explore this scatter interactively →

Exploration